{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:58:03Z","timestamp":1784523483472,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.arth.2017.09.062","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T01:02:26Z","timestamp":1507770146000},"page":"786-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study"],"prefix":"10.1016","volume":"33","author":[{"given":"Ze-Yu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Xing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-2592","authenticated-orcid":false,"given":"Zong-Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2017.09.062_bib1","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0140-6736(12)60607-2","article-title":"Hip arthroplasty","volume":"380","author":"Pivec","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2017.09.062_bib2","first-page":"691","article-title":"Twenty-year accelerated development of artificial joints in China","author":"Ke-Rong","year":"2015","journal-title":"Chin J Joint Surg"},{"key":"10.1016\/j.arth.2017.09.062_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2106\/00004623-199901000-00002","article-title":"An analysis of blood management in patients having a total hip or knee arthroplasty","volume":"81","author":"Bierbaum","year":"1999","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2017.03.009","article-title":"Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis","volume":"153","author":"Xie","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2017.09.062_bib5","first-page":"323","article-title":"Tranexamic acid in total hip arthroplasty: a recursive cumulative meta-analysis of randomized controlled trials and assessment of publication bias","volume":"14","author":"Sridharan","year":"2017","journal-title":"J\u00a0Orthop"},{"key":"10.1016\/j.arth.2017.09.062_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2106\/JBJS.15.00638","article-title":"Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration","volume":"98","author":"Yi","year":"2016","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5301\/hipint.5000291","article-title":"Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial","volume":"26","author":"Xie","year":"2016","journal-title":"Hip Int"},{"key":"10.1016\/j.arth.2017.09.062_bib8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2106\/JBJS.N.00128","article-title":"Perioperative blood transfusions in orthopaedic surgery","volume":"96","author":"Ponnusamy","year":"2014","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib9","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2106\/JBJS.15.01010","article-title":"The Michigan experience with safety and effectiveness of tranexamic acid use in hip and knee arthroplasty","volume":"98","author":"Hallstrom","year":"2016","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib10","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.arth.2014.03.032","article-title":"Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial","volume":"29","author":"Yue","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2106\/JBJS.N.00060","article-title":"Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial","volume":"96","author":"Gomez-Barrena","year":"2014","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib12","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.arth.2016.04.036","article-title":"Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study","volume":"31","author":"Tzatzairis","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib13","first-page":"127","article-title":"A\u00a0randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement","volume":"13","author":"Drosos","year":"2016","journal-title":"J\u00a0Orthop"},{"key":"10.1016\/j.arth.2017.09.062_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2106\/JBJS.16.00188","article-title":"Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial","volume":"99","author":"Kayupov","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2106\/JBJS.J.01095","article-title":"Multimodal pain management after total joint arthroplasty","volume":"93","author":"Parvizi","year":"2011","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-017-3519-x","article-title":"The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial","author":"Lei","year":"2017","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2017.09.062_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.12659\/MSM.900059","article-title":"Comparison of enoxaparin and rivaroxaban in balance of anti-fibrinolysis and anticoagulation following primary total knee replacement: a pilot study","volume":"23","author":"Xie","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arth.2017.09.062_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","article-title":"Estimating allowable blood loss: corrected for dilution","volume":"58","author":"Gross","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.arth.2017.09.062_bib19","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery"},{"key":"10.1016\/j.arth.2017.09.062_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.arth.2010.11.013","article-title":"Hidden blood loss after total hip arthroplasty","volume":"26","author":"Liu","year":"2011","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib21","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.arth.2014.05.026","article-title":"Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial","volume":"29","author":"Huang","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib22","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.arth.2017.06.024","article-title":"Intra-articular application is more effective than intravenous application of tranexamic acid in total knee arthroplasty: a prospective randomized controlled trial","volume":"32","author":"Wang","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.arth.2016.10.003","article-title":"Efficacy of a single dose and an additional dose of tranexamic acid in reduction of blood loss in total knee arthroplasty","volume":"32","author":"Sun","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.arth.2016.06.021","article-title":"The efficacy comparison of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time","volume":"32","author":"Sun","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib25","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.arth.2017.03.059","article-title":"Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study","volume":"32","author":"Yuan","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5792\/ksrr.16.074","article-title":"Blood sparing efficacy of oral tranexamic acid in primary total knee arthroplasty: a randomized controlled trial","volume":"29","author":"Lee","year":"2017","journal-title":"Knee Surg Relat Res"},{"key":"10.1016\/j.arth.2017.09.062_bib27","article-title":"The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty","volume":"25","author":"Cankaya","year":"2017","journal-title":"J\u00a0Orthop Surg (Hong Kong)"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2017.09.062_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","article-title":"The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?","volume":"31","author":"Fillingham","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.transci.2013.09.005","article-title":"Effectiveness of oral tranexamic acid administration on blood loss after knee arthroplasty: a randomized clinical trial","volume":"49","author":"Alipour","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.arth.2017.09.062_bib30","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","article-title":"The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement","volume":"99","author":"Zohar","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.arth.2017.09.062_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2016.06.058","article-title":"Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty","volume":"32","author":"Lee","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib32","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1302\/0301-620X.95B11.31055","article-title":"Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures","volume":"95-B","author":"Irwin","year":"2013","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2017.09.062_bib33","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.arth.2016.04.034","article-title":"Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial","volume":"31","author":"Xie","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.arth.2017.09.062_bib35","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2106\/JBJS.I.01518","article-title":"Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial","volume":"92","author":"Wong","year":"2010","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.09.062_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/ejd.2014.2354","article-title":"Generalized fixed drug eruption induced by tranexamic acid","volume":"24","author":"Kaku","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.arth.2017.09.062_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11096-010-9415-8","article-title":"Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions","volume":"32","author":"Imbesi","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.arth.2017.09.062_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365540903510690","article-title":"Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis","volume":"42","author":"Klak","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.arth.2017.09.062_bib39","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.arth.2016.10.011","article-title":"A\u00a0standardized regimen for the treatment of acute postoperative infections and acute hematogenous infections associated with hip and knee arthroplasties","volume":"32","author":"Fink","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.arth.2015.10.001","article-title":"Cost analysis of tranexamic acid in anemic total joint arthroplasty patients","volume":"31","author":"Phan","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.09.062_bib41","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.arth.2014.01.031","article-title":"Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty","volume":"29","author":"Tuttle","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"issue":"8 Suppl","key":"10.1016\/j.arth.2017.09.062_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.arth.2013.04.054","article-title":"Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty","volume":"28","author":"Gillette","year":"2013","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317308707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317308707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T17:01:53Z","timestamp":1603126913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540317308707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0883540317308707"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2017.09.062","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2017.09.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}